Let's Stop Cervical Cancer

3 Strategies. 1 Goal.

The Path to Cervical Cancer Elimination

Every 2 minutes a woman dies of cervical cancer. We can prevent these deaths, and reach the goal of eliminating cervical cancer by using the following 3 key strategies:

HPV Vaccination

Prevent the disease before it starts. HPV vaccine is one of our most cost-effective tools against cervical cancer, protecting against at least 70% of all cervical cancers.

Screening & Treatment of Precancerous Lesions

Detect early and prevent the progression of the disease. Early detection, diagnosis, and prompt treatment of precancerous lesions are crucial to driving down incidence in the next decades by preventing the development of cervical cancer.

Treatment & Palliative Care of Invasive Cancers

Minimize disability and suffering. Timely availability of and access to quality, affordable treatment and palliative care can help slow the progression of cervical cancer and protect the dignity and quality of life for women living with this disease.

HPV Vaccination

Prevent the disease before it starts. HPV vaccine is one of our most cost-effective tools against cervical cancer, protecting against at least 70% of all cervical cancers.

Screening & Treatment of Precancerous Lesions

Detect early and prevent the progression of the disease. Early detection, diagnosis, and prompt treatment of precancerous lesions are crucial to driving down incidence in the next decades by preventing the development of cervical cancer.

Treatment & Palliative Care of Invasive Cancers

Minimize disability and suffering. Timely availability of and access to quality, affordable treatment and palliative care can help slow the progression of cervical cancer and protect the dignity and quality of life for women living with this disease.

Why cervical cancer?

Cervical cancer is preventable and treatable, yet it is still the fourth most common cancer among women and kills over 300,000 women every year. Concerningly, significant disparities exist: over 90% of these deaths are in low-and middle-income countries.

Why now?

Without action, deaths from cervical cancer are projected to increase 50% by 2040. The WHO’s Global strategy to accelerate the elimination of cervical cancer as a public health problem provides a roadmap to eliminate cervical cancer within the lifetime of today’s youngest girls.

Your action for elimination

Blogs and resources from all around the world

AFRICA ASIA EUROPE NORTHAMERICA OCEANIA SOUTHAMERICA

Latest news and updates

World Cancer Congress Special Working Meeting on HPV Vaccination Report

Since the start of the pandemic and the launch of the Global Strategy, opportunities for collaborative in-person discussion have been limited, but with international travel now permitted for many of our network, the CCAE co-chairs were delighted to host a working meeting at the 2022 World Cancer Congress in Geneva, thereby providing that opportunity for partners and advocates to unite.

Click here to read our World Cancer Congress Special Working Meeting Report.

 

Latest news and updates

Race to None: TogetHER for Health’s fight to eliminate cervical cancer

This year marks five years since TogetHER for Health was formed to drive awareness and action to end cervical cancer, everywhere. In these five years, we’ve seen the movement to eliminate this preventable disease gain momentum and strength.

Latest news and updates

New WHO recommendations for cervical cancer screening and treatment

In July, WHO launched a new guideline to help countries deliver equitable screening and treatment of pre-cancerous cervical lesions. Based on cost-effectiveness modelling, this guideline includes 23 recommendations, some of which are tailored for women living with HIV

Latest news and updates

TogetHER for Health call for prioritisation of HPV testing

It is important that there is global commitment to WHO’s new screening and treatment guideline. Led by TogetHER for Health, CCAE Network and other organisations are calling for high value donors PEPFAR, The Global Fund and USAID to prioritise HPV testing and advance progress towards adoption of this technology